MktsMarkets

Rigel Pharmaceuticals, Inc.
NASDAQ: RIGLKey statistics
RIGL News
Stories mentioning RIGL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 58,818 | 69,802 | 69,462 | 101,685 | 53,333 | 57,596 | 55,307 | 36,841 |
| Cost of Goods Sold | 4,606 | 5,955 | 4,753 | 4,504 | 4,409 | 5,789 | 8,026 | 2,807 |
| Gross Profit | 54,212 | 63,847 | 64,709 | 97,181 | 48,924 | 51,807 | 47,281 | 34,034 |
| Operating Expenses | ||||||||
| Research & Development | 11,676 | 8,436 | ||||||
| Sales General & Admin | 30,651 | 29,992 | 28,936 | 29,257 | 27,715 | 29,520 | 27,043 | 28,047 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 11,885 | 23,170 | 28,420 | 61,103 | 12,773 | 16,655 | 14,056 | 447.00 |
| Interest Income | 1,205 | 1,243 | 1,094 | 753.00 | 591.00 | 522.00 | 425.00 | 552.00 |
| Interest Expense | 1,894 | 1,874 | 1,853 | 1,955 | 2,060 | 2,029 | ||
| Other Expense | ||||||||
| Pretax Income | 11,657 | 22,714 | 27,620 | 59,982 | 11,511 | 15,222 | 12,421 | (1,030) |
| Tax Provision | 3,003 | (245,351) | (280.00) | 369.00 | 65.00 | 881.00 | 0.00 | 0.00 |
| Net Income (Loss) | 8,654 | 268,065 | 27,900 | 59,613 | 11,446 | 14,341 | 12,421 | (1,030) |
| Earnings Per Share (Basic) | 0.47 | 14.90 | 1.55 | 3.33 | 0.64 | 0.82 | 0.71 | (0.06) |
| Earnings Per Share (Diluted) | 0.44 | 14.23 | 1.46 | 3.28 | 0.63 | 0.81 | 0.70 | (0.06) |
| Weighted Average Shares Outstanding (Basic) | 18,412 | 17,987 | 18,038 | 17,885 | 17,808 | 17,579 | 17,600 | 17,549 |
| Weighted Average Shares Outstanding (Diluted) | 19,686 | 18,840 | 19,156 | 18,162 | 18,169 | 17,687 | 17,648 | 17,549 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RIGL
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a stock listed on the Nasdaq Stock Market under the ticker symbol RIGL. It last traded at $42.92 (Nov 17, 2026, 4:00 PM ET), down 1.9% on the day. That gives Rigel Pharmaceuticals a market capitalisation of $823.4M and a price-to-earnings ratio of 2.6.
Over the past 52 weeks RIGL has traded between $24.95 and $52.60.
Revenue for the quarter ended Mar 31, 2026 was $58.8M; net income $8.7M. Revenue was up 10.3% from $53.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $58.8M | $8.7M | 14.7% |
| Dec 31, 2025 | $69.8M | $268.1M | 384.0% |
| Sep 30, 2025 | $69.5M | $27.9M | 40.2% |
| Jun 30, 2025 | $101.7M | $59.6M | 58.6% |
From Rigel Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…